GFAP and Alzheimer disease: Our data showed that A20-driven inhibition of NF-κB leads to suppressing astrocyte reactivity in response to AD-like pathology, as evidenced by the lower levels of multiple proteins commonly upregulated in astrocytes in AD, such as GFAP, IL6, and KC65,66,101.